{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:39:03Z","timestamp":1792798743945,"version":"4.5.0"},"reference-count":52,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"unspecified","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1KL2TR002554"],"award-info":[{"award-number":["1KL2TR002554"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR069572"],"award-info":[{"award-number":["AR069572"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Arthritis Foundation, Arthritis Investigator Award","id":[{"id":"https:\/\/ror.org\/04zk9fe75","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000133","name":"AHRQ","doi-asserted-by":"crossref","award":["1K18HS023443-01A1"],"award-info":[{"award-number":["1K18HS023443-01A1"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2022,2,26]]},"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Multiple guidelines recommend continuing hydroxychloroquine (HCQ) for SLE during pregnancy based on observational data. The goal of this individual patient data meta-analysis was to identify the potential benefits and harms of HCQ use within lupus pregnancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Eligible studies included prospectively collected pregnancies in women with lupus. After a systematic literature search, seven datasets meeting inclusion criteria were obtained. Pregnancy outcomes and lupus activity were compared for pregnancies with a visit in the first trimester in women who did or did not take HCQ throughout pregnancy. Birth defects were not systematically collected. This analysis was conducted in each dataset, and results were aggregated to provide a pooled OR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven cohorts provided 938 pregnancies in 804\u2009women. After selecting one pregnancy per patient with a first trimester visit, 668 pregnancies were included; 63% took HCQ throughout pregnancy. Compared with pregnancies without HCQ, those with HCQ had lower odds of highly active lupus, but did not have different odds of fetal loss, preterm delivery or pre-eclampsia. Among women with low lupus activity, HCQ reduced the odds of preterm delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This large study of prospectively-collected lupus pregnancies demonstrates a decrease in lupus activity among woman who continue HCQ through pregnancy and no harm to pregnancy outcomes. Like all studies of HCQ in lupus pregnancy, this study is confounded by indication and non-adherence. As this study confirms the safety of HCQ and diminished SLE activity with use, it is consistent with current recommendations to continue HCQ throughout pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2021-000651","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T01:05:26Z","timestamp":1647911126000},"page":"e000651","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":66,"title":["Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8579-3470","authenticated-orcid":false,"given":"Megan E B","family":"Clowse","sequence":"first","affiliation":[{"name":"Medicine, Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M","family":"Eudy","sequence":"additional","affiliation":[{"name":"Medicine, Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4016-1680","authenticated-orcid":false,"given":"Stephen","family":"Balevic","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology, Duke University, Durham, North Carolina, USA"},{"name":"The Duke Clinical Research Institute, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Sanders-Schmidler","sequence":"additional","affiliation":[{"name":"Duke-Margolis Center for Health Policy, Duke Clinical Research Institute and Department of Population Health Sciences, Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Kosinski","sequence":"additional","affiliation":[{"name":"Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Fischer-Betz","sequence":"additional","affiliation":[{"name":"Rheumatology, Heinrich-Heine-University, Duesseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna D","family":"Gladman","sequence":"additional","affiliation":[{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Molad","sequence":"additional","affiliation":[{"name":"Rheumtology, Beilinson Hospital, Rabin Medical Center, Petach Tikva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Nalli","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Mokbel","sequence":"additional","affiliation":[{"name":"Medicine, Cairo University, Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Tincani","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7506-9166","authenticated-orcid":false,"given":"Murray","family":"Urowitz","sequence":"additional","affiliation":[{"name":"Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Lupus Clinic, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bay","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"van Noord","sequence":"additional","affiliation":[{"name":"Library, University of California Davis, Davis, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1441-5373","authenticated-orcid":false,"given":"Michelle","family":"Petri","sequence":"additional","affiliation":[{"name":"Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"2025091511474587000_9.1.e000651.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101173240303"},{"key":"2025091511474587000_9.1.e000651.2","doi-asserted-by":"publisher","DOI":"10.1191\/096120398678919778"},{"key":"2025091511474587000_9.1.e000651.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.55.7.486"},{"key":"2025091511474587000_9.1.e000651.4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0961203396005001151","article-title":"Antimalarial drugs in pregnancy--the North American experience","volume":"5 Suppl 1","author":"Parke","year":"1996","journal-title":"Lupus"},{"key":"2025091511474587000_9.1.e000651.5","doi-asserted-by":"publisher","DOI":"10.1191\/096120301678646137"},{"key":"2025091511474587000_9.1.e000651.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.11304"},{"key":"2025091511474587000_9.1.e000651.7","doi-asserted-by":"publisher","DOI":"10.1002\/art.22159"},{"key":"2025091511474587000_9.1.e000651.8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212535"},{"key":"2025091511474587000_9.1.e000651.9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1177\/09612033211007199","article-title":"Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: a meta-analysis","volume":"30","author":"Duan","year":"2021","journal-title":"Lupus"},{"key":"2025091511474587000_9.1.e000651.10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2007-999371","article-title":"Pregnancy outcome following first trimester exposure to chloroquine","volume":"8","author":"Levy","year":"1991","journal-title":"Am J Perinatol"},{"key":"2025091511474587000_9.1.e000651.11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/art.38262","article-title":"Brief report: risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy","volume":"66","author":"Cooper","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025091511474587000_9.1.e000651.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2013.04.005"},{"key":"2025091511474587000_9.1.e000651.13","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.ajog.2020.12.1219","article-title":"Hydroxychloroquine early in pregnancy and risk of birth defects","volume":"224","author":"Huybrechts","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2025091511474587000_9.1.e000651.14","doi-asserted-by":"crossref","first-page":"722511","DOI":"10.3389\/fphar.2021.722511","article-title":"Chloroquine and hydroxychloroquine use during pregnancy and the risk of adverse pregnancy outcomes using real-world evidence","volume":"12","author":"B\u00e9rard","year":"2021","journal-title":"Front Pharmacol"},{"key":"2025091511474587000_9.1.e000651.15","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/rheumatology\/keaa592","article-title":"Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study","volume":"60","author":"Andersson","year":"2021","journal-title":"Rheumatology"},{"key":"2025091511474587000_9.1.e000651.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208840"},{"key":"2025091511474587000_9.1.e000651.17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev404"},{"key":"2025091511474587000_9.1.e000651.18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209770"},{"key":"2025091511474587000_9.1.e000651.19","doi-asserted-by":"crossref","unstructured":"Sammaritano LR , Bermas BL , Chakravarty EE . American College of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol 2020;2020.","DOI":"10.1002\/art.41191"},{"key":"2025091511474587000_9.1.e000651.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.3656"},{"key":"2025091511474587000_9.1.e000651.21","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606"},{"key":"2025091511474587000_9.1.e000651.22","doi-asserted-by":"publisher","DOI":"10.1191\/096120399680411272"},{"key":"2025091511474587000_9.1.e000651.23","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1482"},{"key":"2025091511474587000_9.1.e000651.24","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2025091511474587000_9.1.e000651.25","unstructured":"Team RC . A language and environment for statistical computing. In: R foundation for statistical computing. Vienna, Austria, 2019."},{"key":"2025091511474587000_9.1.e000651.26","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v036.i11"},{"key":"2025091511474587000_9.1.e000651.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919"},{"key":"2025091511474587000_9.1.e000651.28","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-7-9"},{"key":"2025091511474587000_9.1.e000651.29","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12872"},{"key":"2025091511474587000_9.1.e000651.30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jbspin.2018.03.006","article-title":"Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: a systematic review and meta-analysis","volume":"85","author":"Guillotin","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2025091511474587000_9.1.e000651.31","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2235"},{"key":"2025091511474587000_9.1.e000651.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.08.040"},{"key":"2025091511474587000_9.1.e000651.33","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1016\/j.ajog.2015.09.078","article-title":"The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies","volume":"214","author":"Sciascia","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2025091511474587000_9.1.e000651.34","first-page":"639","article-title":"Effect of additional treatments combined with conventional therapies in pregnant patients with high-risk antiphospholipid syndrome: a multicentre study","volume":"118","author":"Ruffatti","year":"2018","journal-title":"Thromb Haemost"},{"key":"2025091511474587000_9.1.e000651.35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semarthrit.2020.10.001","article-title":"The efficacy and safety of second-line treatments of refractory and\/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies","volume":"51","author":"Ruffatti","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2025091511474587000_9.1.e000651.36","first-page":"1","article-title":"Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases","volume":"148","author":"Khizroeva","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025091511474587000_9.1.e000651.37","doi-asserted-by":"crossref","first-page":"102121","DOI":"10.1016\/j.jogoh.2021.102121","article-title":"The additional use of hydroxychloroquine can improve the live birth rate in pregnant women with persistent positive antiphospholipid antibodies: a systematic review and meta-analysis","volume":"50","author":"Tian","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2025091511474587000_9.1.e000651.38","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.autrev.2018.05.012","article-title":"Hibiscus: hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome","volume":"17","author":"Belizna","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2025091511474587000_9.1.e000651.39","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0961203319843343","article-title":"Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia","volume":"28","author":"Seo","year":"2019","journal-title":"Lupus"},{"key":"2025091511474587000_9.1.e000651.40","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/rheumatology\/kex191","article-title":"Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study","volume":"56","author":"Barsalou","year":"2017","journal-title":"Rheumatology"},{"key":"2025091511474587000_9.1.e000651.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.09.020"},{"key":"2025091511474587000_9.1.e000651.42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.089268"},{"key":"2025091511474587000_9.1.e000651.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.045"},{"key":"2025091511474587000_9.1.e000651.44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12026-016-8888-5","article-title":"Obstetric and perinatal outcome in anti-Ro\/SSA-positive pregnant women: a prospective cohort study","volume":"65","author":"Mart\u00ednez-S\u00e1nchez","year":"2017","journal-title":"Immunol Res"},{"key":"2025091511474587000_9.1.e000651.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055202"},{"key":"2025091511474587000_9.1.e000651.46","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/acr.23808","article-title":"Risk of ocular anomalies in children exposed in utero to antimalarials: a systematic literature review","volume":"71","author":"Gaffar","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2025091511474587000_9.1.e000651.47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s40262-018-0712-z","article-title":"Pharmacokinetics of hydroxychloroquine in pregnancies with rheumatic diseases","volume":"58","author":"Balevic","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"2025091511474587000_9.1.e000651.48","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/cpt.885","article-title":"A prospective international study on adherence to treatment in 305 patients with flaring SLE: assessment by drug levels and self-administered questionnaires","volume":"103","author":"Costedoat-Chalumeau","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"2025091511474587000_9.1.e000651.49","doi-asserted-by":"publisher","DOI":"10.1002\/art.22156"},{"key":"2025091511474587000_9.1.e000651.50","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150379"},{"key":"2025091511474587000_9.1.e000651.51","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180158"},{"key":"2025091511474587000_9.1.e000651.52","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev404"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2021-000651","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T18:47:57Z","timestamp":1757962077000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2021-000651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,3,21]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/lupus-2021-000651"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2021-000651","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.21.21267285","asserted-by":"object"}]},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}